Personalising cardiovascular care
And with an individualised experience for you at ESC Congress 2024!
30 Aug 2024“Whatever your interests and career stage, and wherever you are from in the world, we hope to provide an event that both caters to your needs and at the same time, moves our field forward,” says ESC President, Professor Franz Weidinger, as he welcomes everyone to ESC Congress 2024, onsite and online.
“Technological developments continue to advance cardiology and that is why ‘personalising cardiovascular care’ was selected as the spotlight for this congress,” he explains. “Never has taking a personalised approach been so important – and so attainable. Together, we want to explore better ways to provide targeted prevention and new strategies to find the right treatment at the right time for the right person.”
This year’s 12 Hot Line sessions include 38 major trials that have the potential to transform patient management, covering hypertension, atrial fibrillation, structural and coronary interventions, heart failure, coronary artery disease and digital health innovations. This is complemented by an additional 26 Late-Breaking Science sessions on important clinical trial updates, the latest insightful data from large-scale registries and observational studies, and exciting new basic science breakthroughs. In addition, novel findings will be discussed from almost 4,500 scientific abstracts from nearly 100 countries in the Research Gateway, where 378 intriguing clinical cases will also be presented. Plus, a new ESC Guidelines document will be unveiled every day.
Professor John McMurray, ESC Congress Programme Committee Chair, describes the thinking behind one of the new formats, created to enhance the educational and interactive experience: “We have introduced 10 ‘The floor is yours’ sessions where participants can bring their questions on a range of topical issues to an open forum to stimulate shared understanding. Subjects range from treating pulmonary embolism, to the risks of vaping and the regulation of medical devices.”
This year’s spotlight truly places the individual patient at the centre. “Patient voices will resound throughout a new track of sessions designed to ensure that their perspective is always at the forefront,” notes Prof. McMurray, “And another new series of sessions – the obesity track – will help participants delve deeper into one of today’s pressing challenges to improving cardiovascular health.”
Prof. Weidinger concludes: “The strength of the society comes from your individual passion and contribution to activities such as ESC Congress. Collectively, we can make this an exceptional event and shape the future of cardiovascular medicine together.”